Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Fatty acid signatures connect thiamine deficiency with the diet of the Atlantic salmon (Salmo salar) feeding in the Baltic Sea.

Keinänen M, Käkelä R, Ritvanen T, Pönni J, Harjunpää H, Myllylä T, Vuorinen PJ.

Mar Biol. 2018;165(10):161. doi: 10.1007/s00227-018-3418-8. Epub 2018 Oct 1.

2.

TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.

Guillerey C, Harjunpää H, Carrié N, Kassem S, Teo T, Miles K, Krumeich S, Weulersse M, Cuisinier M, Stannard K, Yu Y, Minnie SA, Hill GR, Dougall WC, Avet-Loiseau H, Teng MWL, Nakamura K, Martinet L, Smyth MJ.

Blood. 2018 Oct 18;132(16):1689-1694. doi: 10.1182/blood-2018-01-825265. Epub 2018 Jul 9.

PMID:
29986909
3.

Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23.

Yan J, Allen S, Vijayan D, Li XY, Harjunpää H, Takeda K, Liu J, Cua DJ, Smyth MJ, Teng MWL.

Cancer Immunol Res. 2018 Aug;6(8):978-987. doi: 10.1158/2326-6066.CIR-18-0011. Epub 2018 Jun 19.

PMID:
29921599
4.

Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.

Harjunpää H, Blake SJ, Ahern E, Allen S, Liu J, Yan J, Lutzky V, Takeda K, Aguilera AR, Guillerey C, Mittal D, Li XY, Dougall WC, Smyth MJ, Teng MWL.

Oncoimmunology. 2018 Mar 26;7(7):e1445949. doi: 10.1080/2162402X.2018.1445949. eCollection 2018.

PMID:
29900061
5.

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer.

Ahern E, Harjunpää H, O'Donnell JS, Allen S, Dougall WC, Teng MWL, Smyth MJ.

Oncoimmunology. 2018 Feb 14;7(6):e1431088. doi: 10.1080/2162402X.2018.1431088. eCollection 2018.

PMID:
29872559
6.

Genome sequence of the model plant pathogen Pectobacterium carotovorum SCC1.

Niemi O, Laine P, Koskinen P, Pasanen M, Pennanen V, Harjunpää H, Nykyri J, Holm L, Paulin L, Auvinen P, Palva ET, Pirhonen M.

Stand Genomic Sci. 2017 Dec 20;12:87. doi: 10.1186/s40793-017-0301-z. eCollection 2017.

7.

Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice.

Ahern E, Harjunpää H, Barkauskas D, Allen S, Takeda K, Yagita H, Wyld D, Dougall WC, Teng MWL, Smyth MJ.

Clin Cancer Res. 2017 Oct 1;23(19):5789-5801. doi: 10.1158/1078-0432.CCR-17-0606. Epub 2017 Jun 20.

8.

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.

Liu J, Blake SJ, Yong MC, Harjunpää H, Ngiow SF, Takeda K, Young A, O'Donnell JS, Allen S, Smyth MJ, Teng MW.

Cancer Discov. 2016 Dec;6(12):1382-1399. Epub 2016 Sep 23.

9.

Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer.

Liu J, Blake SJ, Harjunpää H, Fairfax KA, Yong MC, Allen S, Kohrt HE, Takeda K, Smyth MJ, Teng MW.

Cancer Res. 2016 Sep 15;76(18):5288-301. doi: 10.1158/0008-5472.CAN-16-0194. Epub 2016 Aug 8.

10.

In vitro Treg expansion favors the full-length splicing isoform of CTLA4.

Kaartinen T, Harjunpää H, Partanen J, Tiittanen M.

Immunotherapy. 2016 May;8(5):541-53. doi: 10.2217/imt.16.7.

PMID:
27140408
11.

Genome sequence of Pectobacterium sp. strain SCC3193.

Koskinen JP, Laine P, Niemi O, Nykyri J, Harjunpää H, Auvinen P, Paulin L, Pirhonen M, Palva T, Holm L.

J Bacteriol. 2012 Nov;194(21):6004. doi: 10.1128/JB.00681-12. Erratum in: J Bacteriol. 2012 Dec;194(24):7020.

12.

A novel plant ferredoxin-like protein and the regulator Hor are quorum-sensing targets in the plant pathogen Erwinia carotovora.

Sjöblom S, Harjunpää H, Brader G, Palva ET.

Mol Plant Microbe Interact. 2008 Jul;21(7):967-78. doi: 10.1094/MPMI-21-7-0967.

13.

Wireless and inductively powered implant for measuring electrocardiogram.

Riistama J, Väisänen J, Heinisuo S, Harjunpää H, Arra S, Kokko K, Mäntylä M, Kaihilahti J, Heino P, Kellomäki M, Vainio O, Vanhala J, Lekkala J, Hyttinen J.

Med Biol Eng Comput. 2007 Dec;45(12):1163-74. Epub 2007 Oct 11. Review.

PMID:
17929070

Supplemental Content

Loading ...
Support Center